EP 3380103 A1 20181003 - CICATRIZING PHARMACEUTICAL COMPOSITION FOR TOPICAL USE
Title (en)
CICATRIZING PHARMACEUTICAL COMPOSITION FOR TOPICAL USE
Title (de)
NARBENBILDENDE PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR TOPISCHEN VERWENDUNG
Title (fr)
COMPOSITION PHARMACEUTIQUE CICATRISANTE À USAGE TOPIQUE
Publication
Application
Priority
- IT UB20155902 A 20151125
- EP 2016078703 W 20161124
Abstract (en)
[origin: WO2017089475A1] The present invention relates in general terms to a pharmaceutical composition for topical application, comprising an effective combination of hyaluronic acid, beta-glucan, hydrolyzed sericin, and glycerophosphoinositol or a pharmaceutically acceptable salt thereof, useful in particular as a cicatrizing agent for the treatment of micro- cracks and vulvar and/or vaginal epithelium wounds.
IPC 8 full level
A61K 31/683 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 31/045 (2006.01); A61K 31/716 (2006.01); A61K 31/728 (2006.01); A61K 38/17 (2006.01); A61P 15/02 (2006.01); A61P 17/02 (2006.01)
CPC (source: EP)
A61K 9/0014 (2013.01); A61K 9/0034 (2013.01); A61K 9/06 (2013.01); A61K 31/045 (2013.01); A61K 31/683 (2013.01); A61K 31/716 (2013.01); A61K 31/728 (2013.01); A61K 38/012 (2013.01); A61K 38/1767 (2013.01); A61K 47/10 (2013.01); A61K 47/44 (2013.01); A61P 15/02 (2017.12); A61P 17/02 (2017.12)
Citation (search report)
See references of WO 2017089475A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017089475 A1 20170601; EP 3380103 A1 20181003; IT UB20155902 A1 20170525
DOCDB simple family (application)
EP 2016078703 W 20161124; EP 16815558 A 20161124; IT UB20155902 A 20151125